Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TERT | O14746 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24299728 | 1.00 | CYP19A1 (0.41) | CYP19A1TDP1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17147749 | 0.98 | CYP19A1 (0.40) | CYP19A1TDP1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL18981114 | 0.98 | CYP19A1 (0.40) | CYP19A1TDP1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL18981060 | 0.98 | CYP19A1 (0.40) | CYP19A1TDP1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8394084 | 0.96 | CYP19A1 (0.44) | CYP19A1TDP1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17147745 | 0.77 | CYP19A1 (0.44) | CYP19A1TDP1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL12620335 | 0.76 | NLRP3 (0.42) | CYP19A1TDP1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL10933310 | 0.75 | CA1 (0.43) | CYP19A1TDP1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL11291174 | 0.73 | PRSS1 (0.33) | CYP19A1 | |
| SCHEMBL9240777 | 0.72 | MAPT (0.43) | TDP1CYP3A4CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170174802-A1 | COPOLYMER AND MOLDED ARTICLE | KURARAY CO., LTD. (JP) | 2017-06-22 | — | — | US | claimed |
| US-4154962-A | Synthesis of hydratropic acid and some of its alkyl derivatives | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 1979-05-15 | — | — | US | claimed |
| US-20170174802-A1 | COPOLYMER AND MOLDED ARTICLE | KURARAY CO., LTD. (JP) | 2017-06-22 | — | — | US | disclosed |
| US-20170174802-A1 | COPOLYMER AND MOLDED ARTICLE | KURARAY CO., LTD. (JP) | 2017-06-22 | — | — | US | disclosed |
| US-20170174802-A1 | COPOLYMER AND MOLDED ARTICLE | KURARAY CO., LTD. (JP) | 2017-06-22 | — | — | US | disclosed |
| US-8093409-B2 | Method for producing cyclic unsaturated compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-01-10 | — | — | US | disclosed |
| US-8093409-B2 | Method for producing cyclic unsaturated compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20090299009-A1 | METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090299009-A1 | METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 2009-12-03 | — | — | US | disclosed |
| WO-2008023823-A1 | METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-02-28 | — | — | WO | disclosed |
| US-4154962-A | Synthesis of hydratropic acid and some of its alkyl derivatives | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 1979-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090299009-A1 | METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND | FASN, SQLE, ALOX5 | CYP19A1 42/4885TDP1 4807/4885CYP3A4 275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.